Pfizer reports higher profit, but weak sales

Sales slipped to $16.5 billion from $16.6 billion, despite the inclusion of products from recently acquired King Pharmaceuticals. On average, analysts polled by FactSet Research expected Pfizer to earn 29 cents a share, or 58 cents a share on an adjusted...